Exploring immunoregulatory properties of a phenolic-enriched maple syrup extract through integrated proteomics and in vitro assays
- 21 November 2023
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 15 (1) , 172-182
Abstract
Our laboratory has established a comprehensive program to investigate the phytochemical composition and nutritional/medicinal properties of phenolic-enriched maple syrup extract (MSX). Previous studies support MSX's therapeutic potential in diverse disease models, primarily through its anti-inflammatory effects. We recently demonstrated MSX's ability to regulate inflammatory signaling pathways and modulate inflammatory markers and proteins in a lipopolysaccharide (LPS)-induced peritonitis mouse model. However, MSX's immunoregulatory properties remain unknown. Herein, we investigated MSX's immunoregulatory properties for the first time using an integrated approach, combining data-dependent acquisition (DDA) and data-independent acquisition (DIA) strategies in a proteomic analysis of spleen tissue collected from the aforementioned peritonitis mouse model. Additionally, we conducted immune cell activation assays using macrophages and T lymphocytes. The DIA analysis unveiled a distinctive expression pattern involving three proteins—Krt83, Thoc2, and Vps16—which were present in both the control and MSX-treated groups but absent in the LPS-induced model group. Furthermore, proteins Ppih and Dpp9 exhibited significant reductions in the MSX-treated group. Ingenuity pathway analysis indicated that MSX may modulate several critical signaling pathways, exerting a suppressive effect on immune responses in various cell types involved in both innate and adaptive immunity. Our in vitro cell assays supported findings from the proteomics, revealing that MSX significantly reduced the levels of interleukin-1 beta (IL-1β) and tumor necrosis factor-alpha (TNF-α) in LPS-stimulated human macrophage cells, as well as the levels of IL-2 in anti-CD3/anti-CD28-induced Jurkat T cells. Taken together, our investigations provide evidence that MSX exerts immune regulatory effects that impact both innate and adaptive immunity, which adds to the data supporting MSX's development as a functional food.Keywords
Funding Information
- University of Rhode Island
- National Center for Research Resources (P20GM103430)
- National Institutes of Health
- Taneja College of Pharmacy, University of South Florida
This publication has 45 references indexed in Scilit:
- The Nrf2 Activator, tBHQ, Differentially Affects Early Events Following Stimulation of Jurkat CellsToxicological Sciences, 2013
- A Systematic Analysis of the Peripheral and CNS Effects of Systemic LPS, IL-1Β, TNF-α and IL-6 Challenges in C57BL/6 MicePLOS ONE, 2013
- Characterization of murine macrophages from bone marrow, spleen and peritoneumBMC Immunology, 2013
- Anti-inflammatory Effects of Oleanolic Acid on LPS-Induced Inflammation In Vitro and In VivoInflammation, 2012
- Signaling in Innate Immunity and InflammationCold Spring Harbor Perspectives in Biology, 2012
- Further Investigation into Maple Syrup Yields 3 New Lignans, a New Phenylpropanoid, and 26 Other PhytochemicalsJournal of Agricultural and Food Chemistry, 2011
- Maple Syrup Phytochemicals Include Lignans, Coumarins, a Stilbene, and Other Previously Unreported Antioxidant Phenolic CompoundsJournal of Agricultural and Food Chemistry, 2010
- Access to the Spleen Microenvironment through Lymph Shows Local Cytokine Production, Increased Cell Flux, and Altered Signaling of Immune Cells during Lipopolysaccharide-Induced Acute InflammationThe Journal of Immunology, 2010
- Interleukin 2: from immunostimulation to immunoregulation and back againEMBO Reports, 2007
- Acute Inflammatory Response to Endotoxin in Mice and HumansClinical and Vaccine Immunology, 2005